Wang Qing, Lu Youyuan, Mi Xue, Yang Caiyan, Ma Wei, Xia Changbo, Wang Hanqing
College of Pharmacy, Ningxia Medical University, Yinchuan, China.
Department of Pharmacy, The First People's Hospital of Yinchuan, Yinchuan, China.
Pharm Biol. 2025 Dec;63(1):156-169. doi: 10.1080/13880209.2025.2467374. Epub 2025 Feb 25.
Flavones, the key active components in Traditional Chinese Medicine (TCM), have demonstrated antidepressant activity. Given the numerous animal studies conducted, a systematic analysis is essential to provide a valuable reference for future research.
This study investigated the antidepressant activity of flavones based on animal models and summarized the underlying mechanisms.
We systematically searched 7 bibliographic Databases as of August 12, 2023, such as Web of Science, PubMed, China National Knowledge Infrastructure, etc. The meta-analysis was performed using either the random or fixed-effect model, supplemented by trial sequential analysis (TSA). The Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach was used to assess the quality of evidence.
A total of 25 studies involving 458 mice were included, identifying five flavones (baicalin, baicalein, apigenin, luteolin, vitexin) with antidepressant activity. Compared to the control group, flavones significantly reduced immobility time in forced swimming and tail suspension tests. Flavones also decreased serum and hippocampal levels of interleukin (IL)-1β and tumor necrosis factor-alpha (TNF-α), reduced nuclear factor kappa B (NF-κB) levels, and increased brain-derived neurotrophic factor (BDNF) levels. Relative to the positive group, flavones raised IL-6, sucrose preference rate, and corticosterone (CORT) levels, with no significant differences in other factors. The TSA showed the efficacy of flavones for treating depression with adequate 'information size' for the primary outcome.
The results demonstrate that flavones exert protective effects against depression in mice, primarily by stimulating neurotrophic factors and modulating inflammatory pathways. These findings emphasize their potential as promising candidates for the development of novel antidepressant therapies.
黄酮类化合物是中药中的关键活性成分,已显示出抗抑郁活性。鉴于已进行了大量动物研究,进行系统分析对于为未来研究提供有价值的参考至关重要。
本研究基于动物模型研究黄酮类化合物的抗抑郁活性,并总结其潜在机制。
我们系统检索了截至2023年8月12日的7个文献数据库,如科学网、PubMed、中国知网等。采用随机或固定效应模型进行荟萃分析,并辅以试验序贯分析(TSA)。使用推荐分级、评估、制定和评价(GRADE)方法评估证据质量。
共纳入25项研究,涉及458只小鼠,确定了5种具有抗抑郁活性的黄酮类化合物(黄芩苷、黄芩素、芹菜素、木犀草素、牡荆素)。与对照组相比,黄酮类化合物在强迫游泳和悬尾试验中显著缩短了不动时间。黄酮类化合物还降低了血清和海马中白细胞介素(IL)-1β和肿瘤坏死因子-α(TNF-α)的水平,降低了核因子κB(NF-κB)水平,并提高了脑源性神经营养因子(BDNF)水平。相对于阳性组,黄酮类化合物提高了IL-6、蔗糖偏好率和皮质酮(CORT)水平,其他因素无显著差异。TSA显示黄酮类化合物治疗抑郁症的疗效具有足够的“信息大小”用于主要结局。
结果表明,黄酮类化合物对小鼠抑郁症具有保护作用,主要通过刺激神经营养因子和调节炎症途径。这些发现强调了它们作为新型抗抑郁疗法开发的有前途候选物的潜力。